<DOC>
	<DOCNO>NCT00900185</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood patient cancer healthy participant laboratory may help doctor learn change may occur DNA . PURPOSE : This laboratory study look blood sample patient prostate cancer healthy participant identify polymorphism may help study prostate cancer .</brief_summary>
	<brief_title>Study Polymorphism Patients With Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine incidence D104N COL18A1 polymorphism patient prostate cancer . Secondary - Determine incidence polymorphism African-American patient prostate cancer . OUTLINE : This retrospective , multicenter study . DNA extract preexist serum sample polymerase chain reaction perform determine genotype pattern . PROJECTED ACCRUAL : A total 500 patient 250 healthy participant accrue study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis prostate cancer OR healthy participant Patient enrol IRBapproved clinical trial National Cancer Institute Northwestern University , include , limited , follow : NCI99C0052 NCI95C0178 NCI00C003 NCI00C0080 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>